Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
15038 | 734 | 36.1 | 87% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
608 | 3 | CIRCULATING TUMOR CELLS//CEA//CYFRA 21 1 | 14209 |
1634 | 2 | CIRCULATING TUMOR CELLS//DISSEMINATED TUMOR CELLS//CIRCULATING TUMOUR CELLS | 6969 |
15038 | 1 | TTF 1//NAPSIN A//THYROID TRANSCRIPTION FACTOR 1 | 734 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | TTF 1 | authKW | 2558773 | 16% | 53% | 115 |
2 | NAPSIN A | authKW | 1684771 | 7% | 75% | 54 |
3 | THYROID TRANSCRIPTION FACTOR 1 | authKW | 1550692 | 11% | 46% | 81 |
4 | P40 | authKW | 204192 | 2% | 27% | 18 |
5 | TTF1 | authKW | 194979 | 2% | 31% | 15 |
6 | LARGE CELL CARCINOMA | authKW | 179684 | 2% | 24% | 18 |
7 | NKX21 | authKW | 178876 | 3% | 19% | 23 |
8 | THYROID TRANSCRIPTION FACTOR 1 TTF 1 | authKW | 169861 | 1% | 58% | 7 |
9 | TCHRF | address | 136140 | 1% | 55% | 6 |
10 | THYROID TRANSCRIPTION FACTOR I | authKW | 124800 | 0% | 100% | 3 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pathology | 19840 | 46% | 0% | 339 |
2 | Medical Laboratory Technology | 3820 | 12% | 0% | 89 |
3 | Respiratory System | 1275 | 11% | 0% | 83 |
4 | Oncology | 1157 | 22% | 0% | 161 |
5 | Anatomy & Morphology | 927 | 5% | 0% | 37 |
6 | Cell Biology | 555 | 16% | 0% | 115 |
7 | Biochemistry & Molecular Biology | 123 | 15% | 0% | 111 |
8 | Medicine, Research & Experimental | 90 | 5% | 0% | 39 |
9 | Endocrinology & Metabolism | 60 | 5% | 0% | 35 |
10 | Biophysics | 36 | 4% | 0% | 27 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | TCHRF | 136140 | 1% | 55% | 6 |
2 | UNIT PATHOL MED | 83200 | 0% | 100% | 2 |
3 | CELL REGULAT SECT | 56633 | 1% | 17% | 8 |
4 | ADENA CANC | 41600 | 0% | 100% | 1 |
5 | ALBERT BONNIOT ANAT CYTOL PATHOLU823 | 41600 | 0% | 100% | 1 |
6 | ANAT SECTMICROSCOBIO | 41600 | 0% | 100% | 1 |
7 | AREA CONCENTRACAO PATOL VETPROGRAMA POS MED | 41600 | 0% | 100% | 1 |
8 | BIOTHER Y ZHEJIANG PROV P MED | 41600 | 0% | 100% | 1 |
9 | DIAGNOST LEGAL MED SERV | 41600 | 0% | 100% | 1 |
10 | DIPARTIMENTO BIOL PATOL CELLULARE MOL CNR | 41600 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY | 36284 | 5% | 2% | 36 |
2 | MODERN PATHOLOGY | 7285 | 4% | 1% | 29 |
3 | CANCER CYTOPATHOLOGY | 6169 | 2% | 1% | 13 |
4 | JOURNAL OF THORACIC ONCOLOGY | 5587 | 3% | 1% | 19 |
5 | ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE | 3564 | 4% | 0% | 26 |
6 | AMERICAN JOURNAL OF CLINICAL PATHOLOGY | 3556 | 4% | 0% | 27 |
7 | HUMAN PATHOLOGY | 3256 | 3% | 0% | 25 |
8 | DIAGNOSTIC CYTOPATHOLOGY | 3156 | 2% | 0% | 18 |
9 | AMERICAN JOURNAL OF SURGICAL PATHOLOGY | 2700 | 3% | 0% | 20 |
10 | AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY | 2604 | 3% | 0% | 19 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | TTF 1 | 2558773 | 16% | 53% | 115 | Search TTF+1 | Search TTF+1 |
2 | NAPSIN A | 1684771 | 7% | 75% | 54 | Search NAPSIN+A | Search NAPSIN+A |
3 | THYROID TRANSCRIPTION FACTOR 1 | 1550692 | 11% | 46% | 81 | Search THYROID+TRANSCRIPTION+FACTOR+1 | Search THYROID+TRANSCRIPTION+FACTOR+1 |
4 | P40 | 204192 | 2% | 27% | 18 | Search P40 | Search P40 |
5 | TTF1 | 194979 | 2% | 31% | 15 | Search TTF1 | Search TTF1 |
6 | LARGE CELL CARCINOMA | 179684 | 2% | 24% | 18 | Search LARGE+CELL+CARCINOMA | Search LARGE+CELL+CARCINOMA |
7 | NKX21 | 178876 | 3% | 19% | 23 | Search NKX21 | Search NKX21 |
8 | THYROID TRANSCRIPTION FACTOR 1 TTF 1 | 169861 | 1% | 58% | 7 | Search THYROID+TRANSCRIPTION+FACTOR+1+TTF+1 | Search THYROID+TRANSCRIPTION+FACTOR+1+TTF+1 |
9 | THYROID TRANSCRIPTION FACTOR I | 124800 | 0% | 100% | 3 | Search THYROID+TRANSCRIPTION+FACTOR+I | Search THYROID+TRANSCRIPTION+FACTOR+I |
10 | THYROID TRANSCRIPTION FACTOR | 106964 | 1% | 43% | 6 | Search THYROID+TRANSCRIPTION+FACTOR | Search THYROID+TRANSCRIPTION+FACTOR |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | ORDONEZ, NG , (2012) VALUE OF THYROID TRANSCRIPTION FACTOR-1 IMMUNOSTAINING IN TUMOR DIAGNOSIS: A REVIEW AND UPDATE.APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY. VOL. 20. ISSUE 5. P. 429-444 | 108 | 59% | 36 |
2 | ORDONEZ, NG , (2012) THYROID TRANSCRIPTION FACTOR-1 IS NOT EXPRESSED IN SQUAMOUS CELL CARCINOMAS OF THE LUNG: AN IMMUNOHISTOCHEMICAL STUDY WITH REVIEW OF THE LITERATURE.APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY. VOL. 20. ISSUE 6. P. 525-530 | 56 | 88% | 12 |
3 | ORDONEZ, NG , (2012) NAPSIN A EXPRESSION IN LUNG AND KIDNEY NEOPLASIA: A REVIEW AND UPDATE.ADVANCES IN ANATOMIC PATHOLOGY. VOL. 19. ISSUE 1. P. 66 -73 | 61 | 69% | 25 |
4 | YANG, L , LIN, M , RUAN, WJ , DONG, LL , CHEN, EG , WU, XH , YING, KJ , (2012) NKX2-1: A NOVEL TUMOR BIOMARKER OF LUNG CANCER.JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B. VOL. 13. ISSUE 11. P. 855 -866 | 59 | 66% | 6 |
5 | BOGGARAM, V , (2009) THYROID TRANSCRIPTION FACTOR-1 (TTF-1/NKX2.1/TITF1) GENE REGULATION IN THE LUNG.CLINICAL SCIENCE. VOL. 116. ISSUE 1-2. P. 27-35 | 56 | 64% | 68 |
6 | ROSSI, G , PELOSI, G , BARBARESCHI, M , GRAZIANO, P , CAVAZZA, A , PAPOTTI, M , (2013) SUBTYPING NON-SMALL CELL LUNG CANCER: RELEVANT ISSUES AND OPERATIVE RECOMMENDATIONS FOR THE BEST PATHOLOGY PRACTICE.INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY. VOL. 21. ISSUE 4. P. 326-336 | 49 | 58% | 9 |
7 | ORDONEZ, NG , (2012) A WORD OF CAUTION REGARDING NAPSIN A EXPRESSION IN SQUAMOUS CELL CARCINOMAS OF THE LUNG.AMERICAN JOURNAL OF SURGICAL PATHOLOGY. VOL. 36. ISSUE 3. P. 396-401 | 32 | 86% | 12 |
8 | WU, J , CHU, PG , JIANG, Z , LAU, SK , (2013) NAPSIN A EXPRESSION IN PRIMARY MUCIN-PRODUCING ADENOCARCINOMAS OF THE LUNG: AN IMMUNOHISTOCHEMICAL STUDY.AMERICAN JOURNAL OF CLINICAL PATHOLOGY. VOL. 139. ISSUE 2. P. 160-166 | 30 | 88% | 9 |
9 | VINCENTEN, J , SMIT, EF , VOS, W , GRUNBERG, K , POSTMUS, PE , HEIDEMAN, DAM , SNIJDERS, PJF , MEIJER, G , KUIK, J , WITTE, BI , ET AL (2012) NEGATIVE NKX2-1 (TTF-1) AS TEMPORARY SURROGATE MARKER FOR TREATMENT SELECTION DURING EGFR-MUTATION ANALYSIS IN PATIENTS WITH NON-SMALL-CELL LUNG CANCER.JOURNAL OF THORACIC ONCOLOGY. VOL. 7. ISSUE 10. P. 1522-1527 | 41 | 64% | 10 |
10 | LAU, SK , LUTHRINGER, DJ , EISEN, RN , (2002) THYROID TRANSCRIPTION FACTOR-1: A REVIEW.APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY. VOL. 10. ISSUE 2. P. 97-102 | 37 | 82% | 107 |
Classes with closest relation at Level 1 |